European Pharmaceutical Review

DECEMBER 21, 2022

Organic compounds are arguably the foundation of the pharmaceutical industry. All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. EFPIA White Paper on Circular Economy, June 2020. in South San Francisco, CA, USA.

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

Pharmaceutical Technology

FEBRUARY 23, 2023

Our chemists and formulation scientists review the properties of new drug candidates and “work their magic” to develop formulations that improve the exposure profile of the compound. However, the chances of improving the exposure profile of a drug that is highly cleared by formulation modification are limited.

Drug Development 98

Drug Development Compounding Dosage Packaging 98

Pharmaceutical Technology

MARCH 6, 2023

Teijin Pharma is also eligible for up to $200m in potential development and commercial milestone payments along with further additional sales milestones as well as tiered annual net sales royalties. It is committed to developing new therapies for diseases that do not have effective treatment.

Compounding 105

Compounding Communication Drug Development 105

Pharmaceutical Technology

MARCH 22, 2023

Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. FirstLine was developed with a zero-defect philosophy,” explains Santambrogio. “It This was higher than the number of approvals in 2019 and 2020.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52